FDA Strengthens Guidance on Quality Agreements with CMOs

Three years after issuing proposed guidance that laid out the FDA’s expectations for quality agreements with contract manufacturers, the agency has firmed up and expanded what sponsors must do to ensure that their agreements with CMOs are clear and enforceable.
Source: International Pharmaceutical Regulatory Monitor